Open Course 2013
Medical Industry Innovation Forum
[Theme] Leading Innovation in the medical industry - the core of the Growth Strategy
Tetsumon Memorial Hall
(14th Floor, Faculty of Medicine Experimental Research Building)
- Undergraduate and graduate students (from The University of Tokyo and other universities)
- Medical Innovation Industry Institute members
- Healthcare professionals from medical institutes, academic societies, industries including pharmaceutical and medical device companies
- Other professionals with a strong interest in leading Innovation in the medical industry
- Regular: 40,000JPY
- Mi3 Member: 26,000JPY (It costs extra, annual membership fee 12,000 yen)
- Student: Free, for 8 lectures.
The medical industry is expected to play a central role in the growth strategy for Japan’s Economic Revitalization, The country is currently in a favoured, and quite unique position in that medical care is available for the entire population through the social security system. This framework has enabled an eco-system which develops significant medical solutions on a large-scale to meet increasing demand. The needs are changing and demands are increasing, as the population rapidly ages. This is demanding greater human resources in the medical industry, as well as bringing new entrants, from a variety of fields, as new transformational solutions are sought to obviate accelerating cost increases. In these dynamic circumstances, a variety of stakeholders are stressing the need to create a new, world-class, social system, with innovative business models that abhor bureaucracy, encourage collaboration and co-creation, facilitate translational research and empower innovators.
In this year’s course, we will invite top leaders, from different leadership perspectives in industry, government, academic, or medicine, who will share their thoughts and experiences under the common theme of the leading-edge challenges to the future industrial development of the medical industry. We anticipate that these different perspectives will enhance the discussions for making proposals on regulatory reform for a new medical and social system, with transformational business models that reflect closer, public-private partnership
Forum office within Medical Innovation Industry Institute
Tel: +81-3-5842-3363
Presented by Pharmaco-Business Innovation, Graduate School of Pharmaceutical Sciences, the University of Tokyo (Professor: Hiromichi Kimura).
The Forum is sponsored by the Medical Innovation Industry Institute
Program
Hiromichi Kimura
Professor
Graduate School of Pharmaceutical
SciencesThe University of Tokyo
Hiroto Izumi
Director General,Special Advisor to the Prime Minister
Office of Healthcare Policy Cabinet Secretariat
Tatsuhiko Saruwatari
Representative Director, Executive Vice President
TOTO LTD.
Ichiro Kanazawa
Dean
Graduate School, International University of Health and Welfare
Masuhiro Kato
Project Professor
Translational Research Initiative The University of Tokyo
Taketsugu Fujiwara
President
ASAHI KASEI CORPORATION
Shinji Hirai
Governor of Tottori Prefecture
Tottori Prefecture
Osamu Sudoh
Dean
Professor
Graduate School of Interdisciplinary Informatics The University of Tokyo
Tokashiki Naomi
Member of the House of Representatives
Masayo Takahashi
Project Leader
Laboratory for Retinal Regeneration RIKEN Center for Developmental Biology
Akihiro Umezawa
Director
Center for Regenerative Medicine, National Research Institute for Child Health and Development
Shigeo Oyagi
President & CEO
Tijin Limited
Morito Monden
Director
Cancer Institute Hospital of JFCR
Motoki Ozaki
Chairman of the Board
Kao CORPORATION
Masatoshi Narita
Councilor for Pharmaceutical Affairs Minister’s Secretariat
Ministry of Health, Lob our and Welfare
Sadayuki Tsuchiya
Senior Deputy Minister of Education, Culture, Sports, Science and Technology
Yoichi Miyazawa
Member of the House of Councilors